Q2 2023 Xenon Pharmaceuticals Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the Xenon Pharmaceuticals Report Second Quarter 2023 Results Conference Call. (Operator Instructions) After the speakers' presentation, there will be a question-and-answer session.
I will now turn the call over to Sherry Aulin, Chief Financial Officer.
Good afternoon. Thank you for joining us on our call and webcast to discuss Xenon's second quarter 2023 financial and operating results. Joining me are Ian Mortimer, Xenon's President and Chief Executive Officer; Dr. Chris Kenney, Xenon's Chief Medical Officer; and Dr. Chris Von Seggern, Xenon's Chief Commercial Officer. Ian will open today's call with a summary of our proprietary pipeline programs and Chris Kenney will provide an overview of our ongoing XEN1101 clinical program. I will summarize our financial results, progress within our partnered programs and our anticipated company milestone events. Chris Von Seggern will be available during our Q&A session to address
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
